Aisling Capital Management LP: summary

Aisling Capital Management LP reported 14 positions with a reported value of $299.32M in its 13F for Q3 2026. Compared with Q2 2026: 0 new positions, 0 exited.

Top positions

• BRIDGEBIO PHARMA INC
• Syndax Pharmaceuticals Inc
• COMPASS PATHWAYS PLC SPONSORED ADS
• Monte Rosa Therapeutics Inc
• Bicara Therapeutics Inc
• UROGEN PHARMA LTD
• BridgeBio Oncology Therapeutics Inc
• EUPRAXIA PHARMACEUTICALS INC
• BIOMEA FUSION INC
• Aclaris Therapeutics Inc